Fernández, Lucía <br/><br/>
How do we manufacture clinical-grade interleukin-15-stimulated natural killer cell products for cancer treatment?  [electronic resource] 

 -  Transfusion  06 2018 
 - 1340-1347 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1537-2995 
<br/><br/><label>Standard No.: </label>10.1111/trf.14573  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Blood Donors<br/>Cell Culture Techniques--methods<br/>Humans<br/>Immunotherapy, Adoptive--methods<br/>Interleukin-15--pharmacology<br/>K562 Cells<br/>Killer Cells, Natural--cytology<br/>Lymphocyte Count<br/>Methods<br/>Neoplasms--therapy<br/>T-Lymphocytes--cytology